ribavirin has been researched along with gemcitabine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Iovanna, JL; Liu, Y; Neyts, J; Peng, L; Qu, F; Rocchi, P; Wan, J; Wang, M; Xia, Y; Yao, J | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hong, J; Johnson, ZL; Kwon, DY; Lee, JH; Lee, K; Lee, M; Lee, SY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ban, J; Weber, G | 1 |
| Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
| Findenig, G; Fritzer, M; Lhotka, C; Schön, HJ; Szekeres, T | 1 |
| Hata, Y; Prajda, N; Weber, G | 1 |
| Kamio, Y; Mori, N; Murakami, T; Yokooji, T | 1 |
| Ishiguro, M; Kamio, Y; Mori, N; Murakami, T; Shimomukai, Y; Yokooji, T | 1 |
| Cho, S; Choi, K; Choi, M; Han, SB; Kang, H; Kang, M; Kim, C; Kim, DE; Kim, HS; Kim, J; Kim, M; Ko, HJ; Lee, CK; Lee, K; Lee, MY; Lee, SU; Shin, JS; Song, JH; van Kuppeveld, FJ | 1 |
| de Man, RA; Kainov, DE; Li, P; Li, Y; Ma, Z; Pan, Q; Peppelenbosch, MP; Yu, P; Zhang, R | 1 |
4 review(s) available for ribavirin and gemcitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
Role of differentiation induction in action of purine antimetabolites.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Deoxycytidine; Gemcitabine; Humans; Leukemia; Oncogenes; Ribavirin | 1994 |
12 other study(ies) available for ribavirin and gemcitabine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Hepacivirus; Humans; Molecular Conformation; Pancreatic Neoplasms; Ribonucleosides; Structure-Activity Relationship; Triazoles; Virus Replication | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters.
Topics: Animals; Bacterial Proteins; Binding Sites; Biological Transport; Crystallography, X-Ray; Deoxycytidine; Female; Gemcitabine; Gene Expression; Humans; Kinetics; Membrane Transport Proteins; Molecular Docking Simulation; Nucleoside Transport Proteins; Oocytes; Protein Binding; Quantitative Structure-Activity Relationship; Recombinant Proteins; Ribavirin; Substrate Specificity; Thermodynamics; Uridine; Vibrio cholerae; Xenopus laevis | 2014 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gemcitabine; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Promyelocytic, Acute; Liver Neoplasms, Experimental; Models, Biological; Ovarian Neoplasms; Pancreatic Neoplasms; Rats; Ribavirin; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Stem Cell Assay | 1992 |
[Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways].
Topics: Allopurinol; Antimetabolites, Antineoplastic; Benzamidines; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Humans; Hypoxanthine; Hypoxanthines; Ribavirin; Ribonucleotide Reductases; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats.
Topics: Animals; Antimetabolites; Bile Acids and Salts; Biological Availability; Carrier Proteins; Deoxycytidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gemcitabine; In Vitro Techniques; Intestinal Absorption; Male; Membrane Transport Proteins; Nucleosides; Rats; Rats, Sprague-Dawley; Ribavirin; Ribonucleosides | 2008 |
Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile; Biological Availability; Cephalexin; Cholestasis; Chromatography, High Pressure Liquid; Deoxycytidine; Gemcitabine; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Intestinal Absorption; Lipopolysaccharides; Male; Nucleoside Transport Proteins; Rats; Rats, Sprague-Dawley; Ribavirin; Ribonucleosides | 2011 |
Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses.
Topics: Animals; Antiviral Agents; Cell Proliferation; Deoxycytidine; Drug Synergism; Enterovirus; Enterovirus A, Human; Enterovirus Infections; Gemcitabine; HEK293 Cells; HeLa Cells; Humans; Replicon; Ribavirin; Vero Cells; Virus Replication | 2015 |
Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Topics: Antiviral Agents; Cell Line; Deoxycytidine; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gemcitabine; Gene Expression Regulation; Hepatitis E; Hepatitis E virus; Host Microbial Interactions; Humans; Interferon-alpha; Janus Kinases; Mycophenolic Acid; Phosphorylation; Pyrimidine Nucleosides; Response Elements; Ribavirin; Signal Transduction; STAT1 Transcription Factor; Virus Replication | 2020 |